HOLON, Israel, January 26, 2016 /PRNewswire/ --
Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug
discovery company, today announced that the Company will host a
conference call at 10:00 AM EST
on Tuesday, February 9, 2016 to
review fourth quarter and yearend 2015 results. Compugen
participants on the conference call will include Martin Gerstel, Chairman; Dr. Anat Cohen-Dayag, President and CEO; and
Ari Krashin, CFO. The quarterly and
yearend results will be released on the Company's website
(http://www.cgen.com) prior to the call.
To access the conference call, please dial 1-888-668-9141 from
the US, or +972-3-918-0609 internationally. The call will also
be available via live webcast through Compugen's website, located
at the following link.
A replay of the conference call will be available approximately
two hours after the completion of the live conference call. To
access the replay, please dial 1-888-326-9310 from the US or
+972-3-925-5925 internationally. The replay will be available
through February 11, 2016.
About Compugen
Compugen is a leading drug discovery company utilizing its
broadly applicable predictive discovery infrastructure to identify
novel drug targets and develop first-in-class biologics. The
Company's current pipeline primary focus is on immune checkpoint
target candidates discovered by the Company, potentially providing
the basis for a next wave of therapeutics for cancer immunotherapy.
Compugen's business model is based on selectively entering into
collaborations for its novel targets and drug product candidates at
various stages of research and development under revenue-sharing
agreements. The Company is headquartered in Holon, Israel, with R&D facilities in Holon and
South San Francisco. At the US facilities, monoclonal antibody
therapeutic candidates are discovered and developed against the
Company's novel target candidates. For additional information,
please visit Compugen's corporate website at
http://www.cgen.com.
Company contact:
Tsipi Haitovsky
Global Media Liaison
Compugen Ltd.
Email: tsipih@cgen.com
Tel: +972-52-598-9892
SOURCE Compugen Ltd.